Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jan 3;12(1):e054069.
doi: 10.1136/bmjopen-2021-054069.

First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy

Marianna Meschiari  1 , Alessandro Cozzi-Lepri  2 , Roberto Tonelli  3   4 , Erica Bacca  5 , Marianna Menozzi  6 , Erica Franceschini  6 , Gianluca Cuomo  6 , Andrea Bedini  6 , Sara Volpi  5 , Jovana Milic  4   5 , Lucio Brugioni  7 , Elisa Romagnoli  7 , Antonello Pietrangelo  8 , Elena Corradini  8 , Irene Coloretti  9 , Emanuela Biagioni  9 , Stefano Busani  9 , Massimo Girardis  9   10 , Andrea Cossarizza  11 , Enrico Clini  3 , Giovanni Guaraldi  6   5 , Cristina Mussini  6   5 ; Modena COVID-19 Working Group (MoCo19)
Collaborators, Affiliations
Observational Study

First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy

Marianna Meschiari et al. BMJ Open. .

Abstract

Objective: The first COVID-19-19 epidemic wave was over the period of February-May 2020. Since 1 October 2020, Italy, as many other European countries, faced a second wave. The aim of this analysis was to compare the 28-day mortality between the two waves among COVID-19 hospitalised patients.

Design: Observational cohort study. Standard survival analysis was performed to compare all-cause mortality within 28 days after hospital admission in the two waves. Kaplan-Meier curves as well as Cox regression model analysis were used. The effect of wave on risk of death was shown by means of HRs with 95% CIs. A sensitivity analysis around the impact of the circulating variant as a potential unmeasured confounder was performed.

Setting: University Hospital of Modena, Italy. Patients admitted to the hospital for severe COVID-19 pneumonia during the first (22 February-31 May 2020) and second (1 October-31 December 2020) waves were included.

Results: During the two study periods, a total of 1472 patients with severe COVID-19 pneumonia were admitted to our hospital, 449 during the first wave and 1023 during the second. Median age was 70 years (IQR 56-80), 37% women, 49% with PaO2/FiO2 <250 mm Hg, 82% with ≥1 comorbidity, median duration of symptoms was 6 days. 28-day mortality rate was 20.0% (95% CI 16.3 to 23.7) during the first wave vs 14.2% (95% CI 12.0 to 16.3) in the second (log-rank test p value=0.03). After including key predictors of death in the multivariable Cox regression model, the data still strongly suggested a lower 28-day mortality rate in the second wave (aHR=0.64, 95% CI 0.45 to 0.90, p value=0.01).

Conclusions: In our hospitalised patients with COVID-19 with severe pneumonia, the 28-day mortality appeared to be reduced by 36% during the second as compared with the first wave. Further studies are needed to identify factors that may have contributed to this improved survival.

Keywords: COVID-19; epidemiology; respiratory infections.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
DAG of assumptions on causal structure of the data. BMI, body mass index; CCI, Charlson Comorbidity Index; DAG, direct acyclic graph; LDH, lactate dehydrogenase; RS, respiratory support; TCZ, tocilizumab.
Figure 2
Figure 2
Survival Kaplan-Meier estimates stratified by pandemic wave.
See this image and copyright information in PMC

References

    1. Chen N, Zhou M, Dong X, et al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13. 10.1016/S0140-6736(20)30211-7 - DOI - PMC - PubMed
    1. Oke J, Heneghan C. Global Covid-19 case fatality rates. The centre for evidence-based medicine. Available: https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/ [Accessed 17 Apr 2021].
    1. De Natale G, Ricciardi V, De Luca G, et al. . The COVID-19 infection in Italy: a statistical study of an abnormally severe disease. J Clin Med 2020;9. 10.3390/jcm9051564. [Epub ahead of print: 21 May 2020]. - DOI - PMC - PubMed
    1. Hsiang S, Allen D, Annan-Phan S, et al. . The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature 2020;584:262-267. 10.1038/s41586-020-2404-8 - DOI - PubMed
    1. Flaxman S, Mishra S, Gandy A, et al. . Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 2020;584:257–61. 10.1038/s41586-020-2405-7 - DOI - PubMed

Publication types